STOCK TITAN

Equus Total Return Inc (EQS) Financials

EQS
FY2025 annual
Revenue Not reported for FY2025
Net Income -$14.2M +24.6% YoY
EPS (Diluted) -$1.03 +25.4% YoY
Operating Cash Flow -$2.1M -105.6% YoY
Market Cap $14.1M as of Sep 10, 2026
Price / Sales n/m no revenue reported
Price / Earnings n/m net loss, so no earnings multiple, FY2025
Price / Book 0.9x on $16.6M equity, Q4 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD FYE December

Newest figures come from the 10-K/A for FY2025, filed Apr 20, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the EQS SEC filings page.

This page shows Equus Total Return Inc (EQS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI EQS FY2025

The business shows an asset-portfolio mechanic: earnings and operating cash flow swing independently while the balance sheet contracts.

Across FY2023–FY2024, net income changed direction from $12.9M profit to a -$18.8M loss. Operating cash flow moved oppositely, from -$51.4M to $38.2M, showing that reported earnings were not a reliable proxy for cash realization.

The asset contraction is substantial: total assets fell from $93.5M in FY2023 to $21.3M in FY2025. Liabilities also fell from $45.3M to $4.8M, indicating that balance-sheet shrinkage came with reduced obligations rather than being explained only by equity losses.

FY2025’s return on assets was -66.4% and return on equity was -85.5%, showing losses were large relative to the remaining capital base. Interest expense reached $683K in FY2025, making financing costs notable despite the smaller asset base.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

Equus Total Return Inc does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
1/5

Equus Total Return Inc passes 1 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).

Earnings Quality No Cash Backing
N/A

Equus Total Return Inc reported a net loss of $14.2M while operations used $2.1M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

EPS (Diluted)
-$1.34
YoY-69.6%
QoQ-127.1%

Equus Total Return Inc earned -$1.34 per diluted share (EPS) in Q4 2025. This represents a decrease of 69.6% from the same quarter a year earlier. Against the prior quarter it is down 127.1%.

Revenue

Not reported for Q4 2025.

EBITDA

Not reported for Q4 2025.

Net Income

Not reported for Q4 2025.

Cash & Balance Sheet

Cash & Debt
$133K
YoY-49.2%
QoQ-59.6%

Equus Total Return Inc held $133K in cash as of Q4 2025; long-term debt is not reported for that period.

Shares Outstanding
14M
YoY+2.8%
QoQ0.0%

Equus Total Return Inc had 14M shares outstanding in Q4 2025. This represents an increase of 2.8% from the same quarter a year earlier. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q4 2025.

Dividends Per Share

Not reported for Q4 2025.

Margins & Returns

None of these metrics is reported for Q4 2025.

Capital Allocation

None of these metrics is reported for Q4 2025.

EQS Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EQS quarterly income statement
MetricQ4'2510-K/AQ3'2510-Q/AQ2'2510-Q/AQ1'2510-Q/AQ4'2410-K/AQ3'2410-Q/AQ2'2410-Q/AQ1'2410-Q/A
SG&A ExpensesN/A$42K+5.0%$59K-6.3%$48K+45.5%N/A$40K+29.0%$63K+80.0%$33K-5.7%
Interest ExpenseN/A$412K+554.0%$51K+50.0%$29K-9.4%N/A$63K+425.0%$34K+3300.0%$32K+3100.0%
Income TaxN/A$6K+20.0%$10K-9.1%$3K-78.6%N/A$5K+66.7%$11K+57.1%$14K
Net IncomeN/A-$8.1M+15.9%-$86K-102.2%$3.9M+264.6%N/A-$9.6M-236.0%$3.9M-34.4%-$2.4M-111.8%
EPS (Basic)-$0.72+8.9%-$0.59+15.7%-$0.01-103.4%$0.30+276.5%-$0.79-$0.70$0.29-34.1%-$0.17
EPS (Diluted)-$1.34-69.6%-$0.59+15.7%-$0.01$0.25+247.1%-$0.79-1087.5%-$0.70-234.6%$0.29-34.1%-$0.17-112.5%
Diluted Shares (Avg)N/A14M+0.7%14M16M+14.4%N/A14M+0.5%14M+0.5%14M+0.5%

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.

EQS Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EQS quarterly balance sheet
MetricQ4'2510-K/AQ3'2510-Q/AQ2'2510-Q/AQ1'2510-Q/AQ4'2410-K/AQ3'2410-Q/AQ2'2410-Q/AQ1'2410-Q/A
Total Assets$21.3M-28.7%$31.4M-67.1%$37.1M-64.3%$36.5M-63.2%$29.9M-68.0%$95.5M+45.7%$103.8M+95.6%$99.1M+122.8%
Cash & Equivalents$133K-49.2%$329K-71.4%$69K-96.3%$667K-78.1%$262K-96.0%$1.1M-91.6%$1.9M-88.6%$3.0M-82.8%
Short-Term Investments$0$0$10.6M$0$0$0-100.0%$0-100.0%$0-100.0%
Accounts Receivable$1.1M+68.9%$580K+305.6%$1.3M+848.9%$1.0M+636.7%$678K+387.8%$143K+2.1%$139K-57.6%$139K-83.6%
Long-Term Investments$0$0$0$0$0$0$0$0
Total Liabilities$4.8M+1019.2%$4.9M-91.2%$3.0M-94.5%$2.3M-95.7%$426K-99.1%$55.3M+200.7%$54.1M+314.3%$53.2M+412.8%
Total Equity$16.6M-43.8%$26.5M-34.0%$34.1M-31.5%$34.2M-25.5%$29.5M-38.9%$40.2M-14.8%$49.8M+24.3%$45.9M+34.6%
Retained Earnings$59.5M+31.3%-$49.5M-43.0%-$41.4M-65.7%-$41.3M-43.0%$45.3M+270.8%-$34.6M-25.6%-$25.0M+27.8%-$28.9M+28.8%

Not reported in any period shown, so not listed: Current Assets, Inventory, Goodwill, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

EQS Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EQS quarterly cash flow statement
MetricQ4'2510-K/AQ3'2510-Q/AQ2'2510-Q/AQ1'2510-Q/AQ4'2410-K/AQ3'2410-Q/AQ2'2410-Q/AQ1'2410-Q/A
Operating Cash Flow-$196K-100.4%$260K+114.7%-$598K+72.0%-$1.6M+86.0%$53.6M+257.8%-$1.8M+77.0%-$2.1M+49.8%-$11.4M-108.4%
Stock-Based CompensationN/AN/A$433K-9.2%N/AN/A$429K-38.0%$477K+21.4%N/A
Financing Cash Flow$0+100.0%$0-100.0%$0-100.0%$2.0M-75.0%-$55.0M-303.2%$1.0M-79.0%$974K-67.5%$8.0M+100.7%

Not reported in any period shown, so not listed: Depreciation & Amortization, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Dividends Paid, Share Buybacks.

EQS Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EQS quarterly financial ratios
MetricQ4'2510-K/AQ3'2510-Q/AQ2'2510-Q/AQ1'2510-Q/AQ4'2410-K/AQ3'2410-Q/AQ2'2410-Q/AQ1'2410-Q/A
Return on EquityN/A-30.6%-6.6pp-0.3%-8.1pp11.5%+16.8ppN/A-24.0%-39.0pp7.8%-7.0pp-5.2%-1.9pp
Return on AssetsN/A-25.8%-15.7pp-0.2%-4.0pp10.8%+13.2ppN/A-10.1%-20.9pp3.8%-7.4pp-2.4%+0.1pp
Debt-to-Equity0.29+0.3x0.18-1.2x0.09-1.0x0.07-1.1x0.01-0.9x1.38+1.0x1.09+0.8x1.16+0.9x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Current Ratio, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Equus Total Return Inc EQS FY2025 N/A -$14.2M N/A $14.1M
Investcorp Cr Mgmt Bdc Inc ICMB FY2025 N/A -$8.8M N/A $12.4M
US Global Invstr GROW FY2026 $14.4M $3.1M 21.2% $35.2M 54/100
Binah Capital BCG FY2025 $187.1M $2.3M 1.2% $21.6M 18/100
Rand Capital RAND FY2025 N/A -$8.0M N/A $33.1M

Frequently Asked Questions

Is Equus Total Return Inc profitable?

No, Equus Total Return Inc (EQS) reported a net income of -$14.2M in fiscal year 2025.

What is Equus Total Return Inc's earnings per share (EPS)?

Equus Total Return Inc (EQS) reported diluted earnings per share of -$1.03 for fiscal year 2025. This represents a 25.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Equus Total Return Inc's return on equity (ROE)?

Equus Total Return Inc (EQS) has a return on equity of -85.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Equus Total Return Inc (EQS) recorded an outflow of $2.1M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Equus Total Return Inc (EQS) had $21.3M in total assets as of fiscal year 2025, including both current and long-term assets.

Equus Total Return Inc (EQS) had 14M shares outstanding as of fiscal year 2025.

Equus Total Return Inc (EQS) had a debt-to-equity ratio of 0.29 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Equus Total Return Inc (EQS) had a return on assets of -66.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Equus Total Return Inc (EQS) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $14.1M as of Sep 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Equus Total Return Inc (EQS) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $14.1M as of Sep 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Equus Total Return Inc (EQS) has a Piotroski F-Score of 1 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Equus Total Return Inc (EQS) reported a net loss of $14.2M while operations used $2.1M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top